Ubiquinone

DIETARY_SUPPLEMENT4 trials

Sponsors

University of Guadalajara, Minneapolis Veterans Affairs Medical Center, OvationLab, SF Research Institute, Inc.

Conditions

Borderline High LDL-cholesterolDiabetes Mellitus Type 2HealthMyocardial InjuryNon-proliferative Diabetic RetinopathyWellness

Early Phase 1

Anti-oxidant Therapy and Postoperative Cardiac Events (ACE) Trial, Preoperative Intervention in Vascular Surgery

Minneapolis Veterans Affairs Medical CenterMyocardial Injury

Start: 2013-08-05End: 2022-08-04Target: 341Updated: 2021-08-31

Phase 2

Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy

CompletedNCT02062034

University of GuadalajaraDiabetes Mellitus Type 2, Non-proliferative Diabetic Retinopathy

Start: 2011-02-28End: 2014-01-31Updated: 2014-02-13

Comparing the Effects of Commercially Available Dietary Supplements on CoQ10 Concentrations

CompletedNCT06640465

OvationLabHealth, Wellness

Start: 2024-10-12End: 2025-09-17Updated: 2026-03-04

Unknown Phase

Effects of Ubiquinol and Ubiquinone on Vascular Function in Healthy Adults With Borderline High LDL-Cholesterol

Enrolling by invitationNCT07881601

SF Research Institute, Inc.Borderline High LDL-cholesterol

Start: 2026-11-04End: 2027-01-22Target: 120Updated: 2026-10-26

Related Papers

NT-Pro BNP Predicts Myocardial Injury Post-vascular Surgery and is Reduced with CoQ<sub>10</sub>: A Randomized Double-Blind Trial.

2019-10-1719 citations